242
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Enhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluation

, , , , &
Pages 919-926 | Received 31 May 2014, Accepted 17 Jun 2014, Published online: 14 Jul 2014

References

  • Ahmed OAA, Badr-Eldin SM, Tawfik MK, et al. Design and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol-induced hepatotoxicity. J Pharm Sci 2014;103:602–612
  • Ahmed OAA, Afouna MI, El-Say KM, et al. Optimization of self nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches. Expert Opin Drug Deliv 2014;11:1005–1013
  • Dahiya S, Kaushik A. Effect of water soluble carriers on dissolution enhancement of aceclofenac. Asian J Pharm 2010;4:34–40
  • Soni A, Gadad A, Dandagi P, Mastiholimath V. Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: effect of formulation variables. Asian J Pharm 2011;5:57–64
  • Cheng H, Sutton SC, Pipkin JD, et al. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humans. Pharm Res 1993;10:1683–1687
  • Gambhire M, Bhalekar M, Shrivastava B. Bioavailability assessment of simvastatin loaded solid lipid nanoparticles after oral administration. Asian J Pharm Sci 2011;6:251–258
  • Ammar HO, Salama HA, El-Nahhas SA, Elmotasem H. Design and evaluation of chitosan films for transdermal delivery of glimepiride. Curr Drug Deliv 2008;5:290–298
  • Cho CW, Choi JS, Yang KH, Shin SC. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix. Drug Deliv 2009;16:320–330
  • Ball AM, Smith KM. Optimizing transdermal drug therapy. Am J Health Syst Pharm 2008;65:1337–1346
  • Hadgraft J. Advances in transdermal drug delivery. Practitioner 1996;240:656–658
  • Ah YC, Choi JK, Choi YK, et al. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 2010;385:12–19
  • Akimoto T, Nagase Y. Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group. J Contr Rel 2003;88:243–252
  • Alexander A, Dwivedi S, Ajazuddin, et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 2012;164:26–40
  • Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008;364:227–236
  • Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012;64:11–29
  • Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101–114
  • Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond) 2010;5:1595–1616
  • Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci 2008;35:183–192
  • Janga KY, Jukanti R, Sunkavalli S, et al. In situ absorption and relative bioavailability studies of zaleplon loaded self-nanoemulsifying powders. J Microencapsul 2013;30:161–172
  • Ren F, Gao Y, Chen J, et al. New self-nanoemulsifying drug delivery system (SNEDDS) with amphiphilic diblock copolymer methoxy poly (ethylene glycol)-block-poly (-caprolactone). Pharm Dev Technol 2013;18:745–751
  • Singh B, Bandyopadhyay S, Kapil R, et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 2009;26:427–521
  • Singh B, Khurana L, Bandyopadhyay S, et al. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv 2011;18:599–612
  • Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 1995;12:1561–1572
  • Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Del Rev 1997;25:47–58
  • El Maghraby GM. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces 2010;75:595–600
  • Saraf S. Process optimization for the production of nanoparticles for drug delivery applications. Expert Opin Drug Deliv 2009;6:187–196
  • Zidan AS, Sammour OA, Hammad MA, et al. Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci 2007;96:2409–2423
  • Achanta AS, Kowalski JG, Rhodes CT. Artificial neural networks: implications for pharmaceutical sciences. Drug Dev Ind Pharm 1995;21:119–155
  • Wehrlé P, Stamm A. Statistical tools for process control and quality improvement in the pharmaceutical industry. Drug Dev Ind Pharm 1994;20:141–164
  • Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 2009;380:133–141
  • Dixit RP, Barhate CR, Padhye SG, et al. Stability indicating RP-HPLC method for simultaneous determination of simvastatin and ezetimibe from tablet dosage form. Indian J Pharm Sci 2010;72:204–210
  • Li L, Fang L, Xu X, et al. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole. Biopharm Drug Dispos 2010;31:138–149
  • Eggadi V, Ponna SK, Kankanala SR, et al. Determination of simvastatin and diltiazem in rat's plasma by HPLC and pharmacokinetic studies. Int J Pharm Sci Rev Res 2013;21:53–56
  • Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000;S2:S93–S98
  • Fu XC, Wang GP, Liang WQ, Chow MS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release 2004;95:209–216
  • Akimoto T, Kawahara K, Nagase Y, Aoyagi T. Polymeric transdermal drug penetration enhancer. The enhancing effect of oligodimethylsiloxane containing a glucopyranosyl end group. J Control Release 2001;77:49–57
  • Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–618
  • Wahab AFA, Hussein AK, Khaled KA, Ahmed OA. Meloxicam depot parenteral bio-degradable microspheres: preparation, characterization and in-vivo evaluation. Int J Pharm Sci Rev Res 2013;21:38–45
  • Thacharodi D, Panduranga Rao K. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int J Pharm 1994;111:235–240
  • Pathan IB, Setty CM. Enhancement of transdermal delivery of tamoxifen citrate using nanoemulsion vehicle. Int J Pharm Tech Res 2011;3:287–297

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.